Board of Directors member

Dr Pauline Williams is Senior Vice President Global Health R&D in GSK. A physician by training, she has spent over 25 years in drug discovery and development with a focus on clinical pharmacology and translational medicine.

During this time, she instigated several open-innovation models of academic/industry collaboration. In her current role she leads a dedicated team of scientists and physicians working on innovative treatments for Malaria, TB and Kinetoplastid Diseases. She also founded the GSK Non-communicable Diseases Open Lab which provides support to African researchers to address the rising burden of NCDs in sub-Saharan Africa.

In recognition of her contribution to maternal and neonatal health R&D, Pauline was named as a Save the Children Changemaker for Children in 2019. Pauline is a Fellow of the Faculty of Pharmaceutical Medicine, a Fellow of the Academy of Medical Sciences and serves on the Council of the UK Medical Research Council.


We are ViiV Healthcare: 100% dedicated to HIV medicines and research and focused on people living with HIV and AIDS.

Together we are engaged in the HIV response throughout the world, supported by a team of over 1,100 dedicated ViiV Healthcare staff working across the globe.

Discover more about who we are, the work we do and what we're doing to advance HIV science, support the delivery of HIV treatment and care; and work with partners to address the stigma and discrimination faced by people living with HIV.